Picture of Byotrol logo

BYOT Byotrol News Story

0.000.00%
gb flag iconLast trade - 00:00
Consumer DefensivesHighly SpeculativeMicro CapValue Trap

REG - Byotrol PLC - Results of General Meeting

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240422:nRSV5480La&default-theme=true

RNS Number : 5480L  Byotrol PLC  22 April 2024

 

 

Byotrol Plc

("Byotrol" or the "Company")

 

Results of General Meeting

 

Byotrol Plc (AIM: BYOT), the specialist infection prevention and control
company, announces that at the Company's General Meeting held earlier today
all resolutions were duly passed.

 

In accordance with the passing of Resolution 1, the Capital Reorganisation
will become effective at the close of business today.

 

In accordance with the passing of Resolution 3, cancellation of admission of
the Company's ordinary shares to trading on AIM will become effective at
7.00am on 30 April 2024.  In accordance with the passing of Resolution 2, the
Company will re-register as a private limited company with the name Byotrol
Limited which is expected to take place by 21 May 2024.

 

The voting details with regards the General Meeting resolutions will be
detailed on the Company's website, www.byotrol.com

 

Shareholders are reminded that the last day of dealings in Byotrol Plc
ordinary shares on AIM will be 29 April 2024.

 

With effect from the cancellation of admission of the Company's ordinary
shares to trading on AIM, the Company expects to implement a matched bargain
facility in order to facilitate future trading in its shares. A further
announcement will be made in due course.

 

Further details of the cancellation and re-registration are set out in the
circular dated 28 March 2024 ("the Circular").  A copy of the Circular is
available on the Company's website www.byotrol.com (http://www.byotrol.com)

 

Unless otherwise indicated, defined terms in this announcement shall have the
same meaning as described in the Circular.

 

 

 

 

For further information contact:

 

 Byotrol Plc
 Dr Trevor Francis, Non- Executive Chairman                                           +44 (0)1925 742 000
 David Traynor, Interim Chief Executive Officer

 Chris Sedwell, Chief Financial Officer

 Cavendish Capital Markets Limited (Nominated Adviser and Broker)                     +44 (0)20 7220 0500
 Geoff Nash/George Dollemore - Corporate Finance

 Nigel Birks/Harriet Ward - ECM

 Flagstaff Strategic and Investor Communications                                      +44 (0)20 7129 1474
 Tim Thompson/Andrea Seymour/Fergus Mellon                                            byotrol@flagstaffcomms.com (mailto:byotrol@flagstaffcomms.com)

 

 

 

 

This announcement is released by Byotrol Plc and, prior to publication, the
information contained herein was deemed to constitute inside information under
the Market Abuse Regulations (EU) No. 596/2014. Such information is disclosed
in accordance with the Company's obligations under Article 17 of MAR.

 

Notes to editors

 

Byotrol plc (BYOT.L), quoted on AIM, is a specialist infection prevention and
control company, operating globally in the animal and human healthare,
industrial, institutional and consumer sectors, providing low toxicity
products with a broad-based and targeted efficacy across all microbial
classes; bacteria, viruses (including coronavirus), fungi, moulds,
mycobacteria and algae.

 

Byotrol's products can be used stand-alone or as ingredients within existing
products, where they can significantly improve their performance, especially
in personal hygiene, domestic and industrial disinfection, odour control, food
production and food management.

 

Byotrol develops and commercialises technologies that create easier, safer and
cleaner lives for everyone.

 

For more information, go to byotrol.com

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ROMEAALAAADLEFA

Recent news on Byotrol

See all news